PRESS RELEASE published on 06/28/2025 at 00:00, 1 year 4 months ago Onco-Innovations Welcomes AstraZeneca's Interest in Founding Role in PROmAI - an Inka-led AI-Oncology Consortium Onco-Innovations' Inka Health receives Expression of Interest from AstraZeneca to join PROmAI Consortium, advancing AI solutions in oncology. AstraZeneca's involvement reinforces the Consortium's mission of enhancing predictive cancer research Oncology AstraZeneca Onco-Innovations Inka Health PROmAI Consortium
PRESS RELEASE published on 06/28/2025 at 00:00, 1 year 4 months ago NexOptic Technology Corp. Provides Default Status Report on Annual Financial Statements NexOptic Technology Corp. updates on bi-weekly default status report due to delay in filing Annual Financial Statements. Company aims to complete filings by July 14th, 2025 Financial Statements Update Delay NexOptic Technology Corp. Default Status Report
PRESS RELEASE published on 06/27/2025 at 23:30, 1 year 4 months ago Supreme Critical Metals Inc. Provides Update on Late Filing of Annual Financial Disclosure Supreme Critical Metals Inc. provides update on delayed financial filings, obtains interim financing, applies for management cease trade order, and aims to file by August 29, 2025 Management Cease Trade Order Financial Filings Interim Financing Supreme Critical Metals Inc. August 29 2025
PRESS RELEASE published on 06/27/2025 at 23:00, 1 year 4 months ago Orogen Shareholder’s Overwhelmingly Approve Plan of Arrangement with Triple Flag Precious Metals at Annual General and Special Meeting Orogen Royalties Inc. announces shareholder approval of plan of arrangement with Triple Flag, including cash and share consideration. Court approval pending TSX Venture Exchange Orogen Royalties Inc. Plan Of Arrangement Triple Flag Shareholder Voting Results
PRESS RELEASE published on 06/27/2025 at 22:25, 1 year 4 months ago Nepra Foods Announces Closing of First Tranche of a Non-Brokered Private Placement Nepra Foods Inc. closes the first tranche of non-brokered private placement, raising US$274,000 for working capital. Second tranche expected on July 11th, 2025. Securities subject to hold period and restrictions Private Placement Securities Working Capital Nepra Foods Inc. Hold Period
PRESS RELEASE published on 06/27/2025 at 22:17, 1 year 4 months ago EQS-Adhoc: KWS SAAT SE & Co. KGaA: KWS divests stakes in North American joint ventures (AgReliant Genetics) and enters into licensing agreements KWS SAAT SE divests North American joint ventures AgReliant Genetics Inc. and AgReliant Genetics LLC through licensing agreements with GDM, focusing on the European corn business KWS SAAT SE Licensing Agreements Divest AgReliant Genetics European Corn Business
PRESS RELEASE published on 06/27/2025 at 22:00, 1 year 4 months ago Early Warning Report Issued Pursuant to National Instrument 62-103 in Connection with the Conversion of Convertible Debentures of NXT Energy Solutions Inc. MCAPM and Michael P. Mork (Mork Capital) file early warning report on conversion of convertible debentures into Common Shares of NXT, increasing ownership to 28% Convertible Debentures Mork Capital MCAPM Michael P. Mork NXT
PRESS RELEASE published on 06/27/2025 at 19:56, 1 year 4 months ago EQS-Adhoc: 1&1 updates EBITDA forecast for 2025 1&1 AG updates its EBITDA forecast for 2025, expecting approximately €545 million due to higher wholesale costs for national roaming with Vodafone EBITDA Forecast 1&1 AG National Roaming Vodafone 2025 Fiscal Year
PRESS RELEASE published on 06/27/2025 at 19:30, 1 year 4 months ago INFORMATIONS AU TITRE DU PILIER 3 AU 31 MARS 2025 La Caisse Régionale Nord de France publie ses résultats au titre du Pilier III au 31 mars 2025, montrant des ratios de fonds propres, de liquidité et de levier conformes aux exigences réglementaires Liquidité Fonds Propres Pilier III 31 Mars 2025 Caisse Régionale Nord De France
PRESS RELEASE published on 06/27/2025 at 19:14, 1 year 4 months ago Inside Information / Other news releases ABIONYX Pharma announces approval of all resolutions at Combined General Meeting. The biotech company is dedicated to innovative therapies General Meeting Innovative Therapies Biotech Company Resolutions Approval ABIONYX Pharma
Published on 11/06/2026 at 13:00, 3 hours 3 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 3 hours 33 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 3 hours 33 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 05:15, 10 hours 48 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 14:50, 1 hour 12 minutes ago New UN guide keeps people in charge of AI in smart cities
Published on 11/06/2026 at 14:45, 1 hour 18 minutes ago Ningbo Consensus on Collaborative Development released at 2026 Global Mayors Dialogue · Ningbo
Published on 11/06/2026 at 14:40, 1 hour 22 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 11/06/2026 at 09:07, 6 hours 55 minutes ago Mise à disposition de la note d'information de M14 dans le cadre de l'OPR visant les actions BOURRELIER GROUP
Published on 11/06/2026 at 09:04, 6 hours 58 minutes ago Mise à disposition de la note d'information en réponse établie par BOURRELIER GROUP initiée par M14
Published on 11/05/2026 at 18:21, 21 hours 41 minutes ago Capital et droits de vote au 31 octobre 2026